Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Sees Large Decrease in Short Interest

Key Points

• Reckitt Benckiser Group saw a substantial 40.1% decrease in short interest from August 15th to August 31st, with total short shares dropping to 287,200.
• The company announced a dividend payment of $0.2106, payable on September 25th, representing a yield of 341.0%.
• Analyst ratings for Reckitt Benckiser Group are positive, with a consensus rating of "Buy", and several analysts upgrading their ratings for the stock recently.

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) was the recipient of a significant decline in short interest during the month of August. As of August 31st, there was short interest totaling 287,200 shares, a decline of 40.1% from the August 15th total of 479,400 shares. Based on an average daily volume of 439,400 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.0% of the company's stock are short sold. Currently, 0.0% of the company's stock are short sold. Based on an average daily volume of 439,400 shares, the days-to-cover ratio is currently 0.7 days.

Reckitt Benckiser Group Price Performance

Reckitt Benckiser Group stock traded up $0.11 during trading on Monday, reaching $15.77. The company had a trading volume of 8,176 shares, compared to its average volume of 356,216. Reckitt Benckiser Group has a 52 week low of $11.73 and a 52 week high of $15.82. The firm's 50-day simple moving average is $14.75 and its 200 day simple moving average is $13.84. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37.

Reckitt Benckiser Group Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, September 25th. Shareholders of record on Monday, August 11th will be paid a $0.2106 dividend. The ex-dividend date of this dividend is Friday, August 8th. This represents a yield of 341.0%.

Analyst Ratings Changes

RBGLY has been the subject of several research reports. Sanford C. Bernstein raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Royal Bank Of Canada reissued an "outperform" rating on shares of Reckitt Benckiser Group in a report on Friday, July 25th. Four research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Reckitt Benckiser Group currently has a consensus rating of "Buy".

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.